Production of 1,2-diacylglycerol in PC12 cells by nerve growth factor and basic fibroblast growth factor.
The addition of nerve growth factor (NGF) or basic fibroblast growth factor (bFGF) to PC12 cells prelabeled with [3H]inositol and preincubated for 15 min in the presence of 10 mM LiCl stimulated the production of inositol phosphates with maximal increases of 120-180% in inositol monophosphate (IP), 130-200% in inositol bisphosphate (IP2), and 45-50% in inositol trisphosphate (IP3) within 30 min. The majority of the overall increase (approximately 85%) was in IP; the remainder was recovered as IP2 and IP3 (approximately 10% as IP2 and 5% as IP3). Under similar conditions, carbachol (0.5 mM) stimulated about a 10-fold increase in IP, a sixfold increase in IP2, and a fourfold increase in IP3. The mass level of 1,2-diacylglycerol (DG) in PC12 cells was found to be dependent on the incubation conditions; in growth medium [Dulbecco's modified Eagle's medium (DME) plus serum], it was around 6.2 mol %, in DME without serum, 2.5 mol %, and after a 15-min incubation in Dulbecco's phosphate-buffered saline, 0.62 mol %. The addition of NGF and bFGF induced an increase in the mass level of DG of about twofold within 1-2 min, often rising to two- to threefold by 15 min, and then decreasing slightly by 30 min. This increase was dependent on the presence of extracellular Ca2+, and was inhibited by both phenylarsine oxide (25 microM) and 5'-deoxy-5'-methylthioadenosine (3 mM). Under similar conditions, 0.5 mM carbachol stimulated the production of DG to the same extent as 200 ng/ml NGF and 50 ng/ml bFGF. Because carbachol is much more effective in stimulating the production of inositol phosphates, the results suggest that both NGF and bFGF stimulate the production of DG primarily from phospholipids other than the phosphoinositides.
Altin
J G
JG
Department of Biological Chemistry, California College of Medicine, University of California, Irvine 92717.
Bradshaw
R A
RA
D000143:Acids / Q000494:pharmacology; D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology; D000310:Adrenal Gland Neoplasms / Q000378:metabolism* / Q000473:pathology; D000818:Animals; D001152:Arsenicals / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002217:Carbachol / Q000494:pharmacology; D003470:Culture Media; D003839:Deoxyadenosines; D004075:Diglycerides / Q000096:biosynthesis*; D005110:Extracellular Space / Q000378:metabolism; D005346:Fibroblast Growth Factors / Q000494:pharmacology*; D005989:Glycerides / Q000096:biosynthesis*; D007295:Inositol Phosphates / Q000378:metabolism; D009414:Nerve Growth Factors / Q000494:pharmacology*; D010673:Pheochromocytoma / Q000378:metabolism* / Q000473:pathology; D011188:Potassium / Q000378:metabolism; D013872:Thionucleosides / Q000494:pharmacology; D014407:Tumor Cells, Cultured
C011439:1,2-diacylglycerol; D000143:Acids; D001152:Arsenicals; D003470:Culture Media; D003839:Deoxyadenosines; D004075:Diglycerides; D005989:Glycerides; D007295:Inositol Phosphates; D009414:Nerve Growth Factors; D013872:Thionucleosides; C029341:oxophenylarsine; D005346:Fibroblast Growth Factors; C008500:5'-methylthioadenosine; D002217:Carbachol; D000241:Adenosine; D011188:Potassium; D002118:Calcium